Metoclopramide Hydrochloride
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 4 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 3 | SUPPLYING |
| Teva Parenteral Medicines, Inc. | unknown | 2 | SUPPLYING |
| Hospira, Inc. | brand | 2 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 2 | SUPPLYING |
| ProPharma Distribution | relabeler | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Lack of Assurance of Sterility — Recalling firm: Teva Pharmaceuticals USA — Product was distributed Nationwide, including Puerto Rico.
Lack of Assurance of Sterility — Recalling firm: Teva Pharmaceuticals USA — Product was distributed nationwide.
Chemical contamination; Unknown brown residue adhering to the inside of one vial. — Recalling firm: Teva Pharmaceuticals USA — Nationwide, including Puerto Rico
Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products. — Recalling firm: Teva Pharmaceuticals USA — Product was distributed nationwide in the USA and Puerto Rico.
Presence of Particulate Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico
